Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Gut microbiota-host interactions appear to play a role in the pathophysiology and symptoms of irritable bowel syndrome (IBS), according to evidence (1)
It is a multicenter, randomized, double-blind, cross-over, 18-week, placebo-controlled, pilot treatment trial studying Lacticaseibacillus paracasei CNCM I-1572 or placebo in 40 enrolled patients with Irritable Bowel Syndrome (IBS) (1)
Symptoms, gut microbiota composition, fecal short chain fatty acid (SCFA), immunoglobulin A, and cytokines (1)
The administration of [Lacticaseibacillus paracasei CNCM I-1572](brain://-m5JUik30U2FHha7poX41w/Lactic…